Prevalence, Predictors, and Outcomes of Patients With ST-Elevation Myocardial Infarction and Angiographically
Nir Levi1, Ziv Dadon2, Yoed Steinmetz2
1Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel.
Insights
Nearly 20% of ST-elevation myocardial infarction patients have significant non-infarct-related artery coronary artery disease. This condition, linked to older age, male gender, and diabetes, increases mortality risk.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- ST-elevation myocardial infarction (STEMI) management often focuses on the infarct-related artery (IRA).
- However, significant coronary artery disease (CAD) in non-IRA vessels may impact patient outcomes.
- Understanding the prevalence and predictors of non-IRA CAD in STEMI is crucial for comprehensive treatment strategies.
Purpose of the Study:
- To determine the prevalence of angiographically significant non-IRA CAD in patients with STEMI.
- To identify independent predictors associated with the presence of non-IRA CAD.
- To evaluate the impact of non-IRA CAD on short- and long-term all-cause mortality.
Main Methods:
- Retrospective analysis of consecutive STEMI patients undergoing primary percutaneous coronary intervention (2000-2020).
- Definition of significant CAD: >50% left main stenosis or >90% stenosis in other arteries.
- Statistical analysis to identify predictors and compare mortality rates between groups (IRA-only CAD vs. non-IRA CAD).
Main Results:
- A total of 3,320 patients were analyzed; 19.8% (657) had significant non-IRA CAD.
- Independent predictors for non-IRA CAD included male gender, age >50 years, and diabetes mellitus.
- Smoking and family history of CAD were negatively associated with non-IRA CAD.
- Patients with non-IRA CAD exhibited significantly higher in-hospital, 30-day, 1-year, and 5-year all-cause mortality rates.
Conclusions:
- Approximately 20% of STEMI patients present with significant non-IRA CAD.
- Older age, male gender, and diabetes are key predictors of non-IRA CAD.
- The presence of non-IRA CAD is a significant independent predictor of increased short- and long-term mortality in STEMI patients.
Abstract:
Patients with ST-elevation myocardial infarction (STEMI) can present with angiographically significant coronary artery disease (CAD) of non-infarct-related artery (IRA) or with IRA-only CAD. This study aimed to evaluate the prevalence, predictors, and outcome of patients with STEMI and angiographically significant CAD of non-IRA. All consecutive patients with STEMI who underwent primary percutaneous coronary intervention between 2000 and 2020 were included. Angiographically significant CAD was defined as >50% stenosis of the left main coronary artery and/or >90% stenosis for all other coronary arteries. A total of 2,663 patients had IRA-only CAD (80.2%) and 657 had angiographically significant non-IRA CAD (19.8%). Independent predictors for non-IRA CAD were male gender (odds ratio [OR] 1.34, 95% confidence interval [CI] 1.05 to 1.70, p = 0.021), age >50 years (OR 1.45, 95% CI 1.11 to 1.91, p = 0.007), and diabetes mellitus (OR 1.56, 95% CI 1.29 to 1.9, p <0.001), whereas smoking (OR 0.83, 95% CI 0.68 to 0.99, p = 0.004) and family history of CAD (OR 0.78, 95% CI 0.62 to 0.98, p = 0.032) were found to be negatively associated with non-IRA CAD. In-hospital 30-day and 1- and 5-year all-cause mortality were higher in patients with non-IRA CAD compared with IRA-only CAD (5.8% vs 2.5%, 8.5% vs 3.3%, 18.4% vs 7.6% and 36.3% vs 20.3%, respectively; p for all <0.001). In conclusion, 20% of patients with STEMI had angiographically significant non-IRA CAD. Older age, male gender, and diabetes mellitus were independent predictors for non-IRA CAD, whereas smoking and family history of CAD predicted IRA-only CAD. The presence of non-IRA CAD was associated with higher short- and long-term all-cause mortality rates.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
